Venetia Zachariou - Publications

University of Crete, Giofirakia, Greece 
Behavioral and Molecular Pharmacology

80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Serafini RA, Estill M, Pekarskaya EA, Sakloth F, Shen L, Javitch JA, Zachariou V. Tianeptine promotes lasting antiallodynic effects in a mouse model of neuropathic pain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 37474762 DOI: 10.1038/s41386-023-01645-w  0.337
2023 Pryce KD, Serafini RA, Ramakrishnan A, Nicolais A, Giosan IM, Polizu C, Torres-Berrío A, Vuppala S, Kronman H, Ruiz A, Gaspari S, Peña CJ, Sakloth F, Mitsi V, van Duzer J, ... ... Zachariou V, et al. Oxycodone withdrawal induces HDAC1/HDAC2-dependent transcriptional maladaptations in the reward pathway in a mouse model of peripheral nerve injury. Nature Neuroscience. PMID 37291337 DOI: 10.1038/s41593-023-01350-3  0.82
2022 Sakloth F, Sanchez Reyes OB, Ruiz A, Nicolais A, Serafini RA, Pryce KD, Bertherat F, Torres Berrio A, Gomes I, Devi LA, Wacker D, Zachariou V. . Molecular Pharmacology. PMID 36310031 DOI: 10.1124/molpharm.122.000528  0.825
2022 Williams AV, Peña CJ, Ramos-Maciel S, Laman-Maharg A, Ordoñez-Sanchez E, Britton M, Durbin-Johnson B, Settles M, Hao R, Yokoyama S, Xu C, Luo PX, Dwyer T, Bhela S, Black AM, ... ... Zachariou V, et al. Comparative Transcriptional Analyses in the Nucleus Accumbens Identifies RGS2 as a Key Mediator of Depression-Related Behavior. Biological Psychiatry. PMID 36075764 DOI: 10.1016/j.biopsych.2022.06.030  0.752
2022 Serafini RA, Frere JJ, Zimering J, Giosan IM, Pryce KD, Golynker I, Panis M, Ruiz A, tenOever B, Zachariou V. SARS-CoV-2 Airway Infection Results in Time-dependent Sensory Abnormalities in a Hamster Model. Biorxiv : the Preprint Server For Biology. PMID 36032984 DOI: 10.1101/2022.08.19.504551  0.767
2022 Frere JJ, Serafini RA, Pryce KD, Zazhytska M, Oishi K, Golynker I, Panis M, Zimering J, Horiuchi S, Hoagland DA, Møller R, Ruiz A, Kodra A, Overdevest JB, Canoll PD, ... ... Zachariou V, et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery. Science Translational Medicine. eabq3059. PMID 35857629 DOI: 10.1126/scitranslmed.abq3059  0.768
2021 Pryce KD, Kang HJ, Sakloth F, Liu Y, Khan S, Toth K, Kapoor A, Nicolais A, Che T, Qin L, Bertherat F, Kaniskan HÜ, Jin J, Cameron MD, Roth BL, ... Zachariou V, et al. A Promising Chemical Series of Positive Allosteric Modulators of the μ-Opioid Receptor that Enhance the Antinociceptive Efficacy of Opioids but not their Adverse Effects. Neuropharmacology. 108673. PMID 34153316 DOI: 10.1016/j.neuropharm.2021.108673  0.3
2020 Sakloth F, Polizu C, Bertherat F, Zachariou V. Regulators of G protein signaling in analgesia and addiction. Molecular Pharmacology. PMID 32474445 DOI: 10.1124/mol.119.119206  0.427
2020 Sakloth F, Manouras L, Avrampou K, Mitsi V, Serafini RA, Pryce KD, Cogliani V, Berton O, Jarpe M, Zachariou V. HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice. Psychopharmacology. PMID 32388618 DOI: 10.1007/s00213-020-05525-9  0.763
2020 Serafini RA, Pryce KD, Zachariou V. The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities. Biological Psychiatry. 87: 64-73. PMID 31806085 DOI: 10.1016/j.biopsych.2019.10.018  0.801
2020 Pryce KD, Kronman H, Ramakrishnan A, Torres-Berrio A, Polizu CD, Pena C, Shen LD, Nestler E, Zachariou V. Oxycodone‐induced Gene adaptations in the brain reward center in a murine Model of Neuropathic pain The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.04088  0.786
2020 Sakloth F, Singh M, Serafini R, Gomes I, Devi L, Zachariou V. RGSz1 actions in the periaqueductal gray modulate opioid reward and analgesic tolerance The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.03381  0.396
2020 Serafini RA, Sakloth F, Pryce K, Bertherat F, Akbarian S, Zachariou V. MEF2C Mediates Chronic Pain in Rodent Neuropathy Models The Faseb Journal. 34: 1-1. DOI: 10.1096/fasebj.2020.34.s1.02107  0.324
2019 Avrampou K, Pryce KD, Ramakrishnan A, Sakloth F, Gaspari S, Serafini RA, Mitsi V, Polizu C, Swartz C, Ligas B, Richards A, Shen L, Carr FB, Zachariou V. RGS4 maintains chronic pain symptoms in rodent models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31308097 DOI: 10.1523/JNEUROSCI.3154-18.2019  0.809
2019 Serafini RA, Zachariou V. Opioid-galanin receptor heteromers differentiate the dopaminergic effects of morphine and methadone. The Journal of Clinical Investigation. 130. PMID 31135380 DOI: 10.1172/JCI128987  0.81
2018 Bonsi P, Ponterio G, Vanni V, Tassone A, Sciamanna G, Migliarini S, Martella G, Meringolo M, Dehay B, Doudnikoff E, Zachariou V, Goodchild RE, Mercuri NB, D'Amelio M, Pasqualetti M, et al. RGS9-2 rescues dopamine D2 receptor levels and signaling in dystonia mouse models. Embo Molecular Medicine. PMID 30552094 DOI: 10.15252/Emmm.201809283  0.348
2018 Gaspari S, Purushothaman I, Cogliani V, Sakloth F, Neve RL, Howland D, Ring RH, Ross EM, Shen L, Zachariou V. Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway. Proceedings of the National Academy of Sciences of the United States of America. PMID 29440403 DOI: 10.1073/Pnas.1707887115  0.448
2017 Chen Y, Booth C, Wang H, Wang R, Terzi D, Zachariou V, Jiao K, Zhang J, Wang Q. Effective attenuation of adenosine A1R signaling by neurabin requires oligomerization of neurabin. Molecular Pharmacology. PMID 28954816 DOI: 10.1124/Mol.117.109462  0.32
2017 Zhang H, Qian YL, Li C, Liu D, Wang L, Wang XY, Liu MJ, Liu H, Zhang S, Guo XY, Yang JX, Ding HL, Koo JW, Mouzon E, Deisseroth K, ... ... Zachariou V, et al. Brain-Derived Neurotrophic Factor in the Mesolimbic Reward Circuitry Mediates Nociception in Chronic Neuropathic Pain. Biological Psychiatry. PMID 28390647 DOI: 10.1016/J.Biopsych.2017.02.1180  0.666
2017 Descalzi G, Mitsi V, Purushothaman I, Gaspari S, Avrampou K, Loh YE, Shen L, Zachariou V. Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression. Science Signaling. 10. PMID 28325815 DOI: 10.1126/Scisignal.Aaj1549  0.734
2017 Gaspari S, Cogliani V, Manouras L, Anderson EM, Mitsi V, Avrampou K, Carr FB, Zachariou V. RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28074831 DOI: 10.1038/npp.2017.4  0.47
2016 Krystal JH, Abi-Dargham A, Akbarian S, Arnsten AF, Barch DM, Bearden CE, Braff DL, Brown ES, Bullmore ET, Carlezon WA, Carter CS, Cook EH, Daskalakis ZJ, DiLeone RJ, Duman RS, ... ... Zachariou V, et al. Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research. Biological Psychiatry. 80: 84-6. PMID 27346079 DOI: 10.1016/J.Biopsych.2016.05.004  0.726
2016 Mitsi V, Zachariou V. Modulation of pain, nociception, and analgesia by the brain reward center. Neuroscience. PMID 27189881 DOI: 10.1016/j.neuroscience.2016.05.017  0.413
2016 Gacias M, Gaspari S, Mae-Santos P, Tamburini S, Andrade M, Zang F, Shen N, Tolstikov V, Kiebish MA, Dupree JL, Zachariou V, Clemente JC, Casaccia P. Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior. Elife. 5. PMID 27097105 DOI: 10.7554/Elife.13442  0.343
2015 Mitsi V, Terzi D, Purushothaman I, Manouras L, Gaspari S, Neve RL, Stratinaki M, Feng J, Shen L, Zachariou V. RGS9-2-controlled adaptations in the striatum determine the onset of action and efficacy of antidepressants in neuropathic pain states. Proceedings of the National Academy of Sciences of the United States of America. 112: E5088-97. PMID 26305935 DOI: 10.1073/Pnas.1504283112  0.572
2015 Descalzi G, Ikegami D, Ushijima T, Nestler EJ, Zachariou V, Narita M. Epigenetic mechanisms of chronic pain. Trends in Neurosciences. 38: 237-46. PMID 25765319 DOI: 10.1016/J.Tins.2015.02.001  0.756
2015 Caldarone BJ, Zachariou V, King SL. Rodent models of treatment-resistant depression. European Journal of Pharmacology. 753: 51-65. PMID 25460020 DOI: 10.1016/j.ejphar.2014.10.063  0.687
2015 Descalzi G, Ikegami D, Ushijima T, Nestler EJ, Zachariou V, Narita M. Erratum: Epigenetic mechanisms of chronic pain Trends in Neurosciences. 38: 579. DOI: 10.1016/J.Tins.2015.07.002  0.716
2014 Terzi D, Gaspari S, Manouras L, Descalzi G, Mitsi V, Zachariou V. RGS9-2 modulates sensory and mood related symptoms of neuropathic pain. Neurobiology of Learning and Memory. 115: 43-8. PMID 25150149 DOI: 10.1016/J.Nlm.2014.08.005  0.734
2014 Carr FB, Zachariou V. Nociception and pain: lessons from optogenetics. Frontiers in Behavioral Neuroscience. 8: 69. PMID 24723861 DOI: 10.3389/fnbeh.2014.00069  0.359
2014 Gaspari S, Papachatzaki MM, Koo JW, Carr FB, Tsimpanouli ME, Stergiou E, Bagot RC, Ferguson D, Mouzon E, Chakravarty S, Deisseroth K, Lobo MK, Zachariou V. Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1968-77. PMID 24561386 DOI: 10.1038/Npp.2014.45  0.809
2013 Stratinaki M, Varidaki A, Mitsi V, Ghose S, Magida J, Dias C, Russo SJ, Vialou V, Caldarone BJ, Tamminga CA, Nestler EJ, Zachariou V. Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models. Proceedings of the National Academy of Sciences of the United States of America. 110: 8254-9. PMID 23630294 DOI: 10.1073/Pnas.1214696110  0.817
2013 Sarhan M, Pawlowski SA, Barthas F, Yalcin I, Kaufling J, Dardente H, Zachariou V, Dileone RJ, Barrot M, Veinante P. BDNF parabrachio-amygdaloid pathway in morphine-induced analgesia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 1649-60. PMID 23425507 DOI: 10.1017/S146114571200168X  0.653
2013 Stratinaki M, Varidaki A, Mitsi V, Ghose S, Magida J, Dias C, Russo SJ, Vialou V, Caldarone BJ, Tamminga CA, Nestler EJ, Zachariou V. Regulator of G protein signaling is a crucial modulator of antidepressant drug action in depression and neuropathic pain models(Proceedings of the National Academy of Sciences of the United States of America (2013) 110, 20 (8254-8259)) Proceedings of the National Academy of Sciences of the United States of America. 110: 11660. DOI: 10.1073/Pnas.1311399110  0.787
2012 Sun H, Maze I, Dietz DM, Scobie KN, Kennedy PJ, Damez-Werno D, Neve RL, Zachariou V, Shen L, Nestler EJ. Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 17454-64. PMID 23197736 DOI: 10.1523/Jneurosci.1357-12.2012  0.796
2012 Terzi D, Cao Y, Agrimaki I, Martemyanov KA, Zachariou V. R7BP modulates opiate analgesia and tolerance but not withdrawal. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1005-12. PMID 22089315 DOI: 10.1038/Npp.2011.284  0.445
2012 Holmes FE, Armenaki A, Iismaa TP, Einstein EB, Shine J, Picciotto MR, Wynick D, Zachariou V. Galanin negatively modulates opiate withdrawal via galanin receptor 1. Psychopharmacology. 220: 619-25. PMID 21969124 DOI: 10.1007/S00213-011-2515-X  0.809
2012 Zachariou V, Duman RS, Nestler EJ. G Proteins Basic Neurochemistry. 411-422. DOI: 10.1016/B978-0-12-374947-5.00021-3  0.331
2011 Waugh JL, Celver J, Sharma M, Dufresne RL, Terzi D, Risch SC, Fairbrother WG, Neve RL, Kane JP, Malloy MJ, Pullinger CR, Gu HF, Tsatsanis C, Hamilton SP, Gold SJ, ... Zachariou V, et al. Association between regulator of G protein signaling 9-2 and body weight. Plos One. 6: e27984. PMID 22132185 DOI: 10.1371/Journal.Pone.0027984  0.694
2011 Sim-Selley LJ, Cassidy MP, Sparta A, Zachariou V, Nestler EJ, Selley DE. Effect of ΔFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens. Neuropharmacology. 61: 1470-6. PMID 21907220 DOI: 10.1016/J.Neuropharm.2011.08.046  0.593
2011 Papachatzaki MM, Antal Z, Terzi D, Szücs P, Zachariou V, Antal M. RGS9-2 modulates nociceptive behaviour and opioid-mediated synaptic transmission in the spinal dorsal horn. Neuroscience Letters. 501: 31-4. PMID 21741448 DOI: 10.1016/j.neulet.2011.06.033  0.393
2011 Psifogeorgou K, Psigfogeorgou K, Terzi D, Papachatzaki MM, Varidaki A, Ferguson D, Gold SJ, Zachariou V. A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 5617-24. PMID 21490202 DOI: 10.1523/Jneurosci.4146-10.2011  0.602
2011 Coogan AN, Papachatzaki MM, Clemens C, Baird A, Donev RM, Joosten J, Zachariou V, Thome J. Haloperidol alters circadian clock gene product expression in the mouse brain. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 638-44. PMID 21250933 DOI: 10.3109/15622975.2010.543149  0.336
2010 Han MH, Renthal W, Ring RH, Rahman Z, Psifogeorgou K, Howland D, Birnbaum S, Young K, Neve R, Nestler EJ, Zachariou V. Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia. Biological Psychiatry. 67: 761-9. PMID 19914603 DOI: 10.1016/J.Biopsych.2009.08.041  0.812
2009 Terzi D, Stergiou E, King SL, Zachariou V. Regulators of G protein signaling in neuropsychiatric disorders. Progress in Molecular Biology and Translational Science. 86: 299-333. PMID 20374720 DOI: 10.1016/S1877-1173(09)86010-9  0.572
2009 Traynor JR, Terzi D, Caldarone BJ, Zachariou V. RGS9-2: probing an intracellular modulator of behavior as a drug target. Trends in Pharmacological Sciences. 30: 105-11. PMID 19211160 DOI: 10.1016/  0.696
2008 Krishnan V, Graham A, Mazei-Robison MS, Lagace DC, Kim KS, Birnbaum S, Eisch AJ, Han PL, Storm DR, Zachariou V, Nestler EJ. Calcium-sensitive adenylyl cyclases in depression and anxiety: behavioral and biochemical consequences of isoform targeting. Biological Psychiatry. 64: 336-43. PMID 18468583 DOI: 10.1016/J.Biopsych.2008.03.026  0.783
2008 Charlton JJ, Allen PB, Psifogeorgou K, Chakravarty S, Gomes I, Neve RL, Devi LA, Greengard P, Nestler EJ, Zachariou V. Multiple actions of spinophilin regulate mu opioid receptor function. Neuron. 58: 238-47. PMID 18439408 DOI: 10.1016/J.Neuron.2008.02.006  0.652
2008 Fischer SJ, Arguello AA, Charlton JJ, Fuller DC, Zachariou V, Eisch AJ. Morphine blood levels, dependence, and regulation of hippocampal subgranular zone proliferation rely on administration paradigm. Neuroscience. 151: 1217-24. PMID 18248906 DOI: 10.1016/j.neuroscience.2007.11.035  0.651
2008 Zachariou V, Liu R, LaPlant Q, Xiao G, Renthal W, Chan GC, Storm DR, Aghajanian G, Nestler EJ. Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies. Biological Psychiatry. 63: 1013-21. PMID 18222416 DOI: 10.1016/J.Biopsych.2007.11.021  0.762
2008 Hooks SB, Martemyanov K, Zachariou V. A role of RGS proteins in drug addiction. Biochemical Pharmacology. 75: 76-84. PMID 17880927 DOI: 10.1016/J.Bcp.2007.07.045  0.362
2007 Psifogeorgou K, Papakosta P, Russo SJ, Neve RL, Kardassis D, Gold SJ, Zachariou V. RGS9-2 is a negative modulator of mu-opioid receptor function. Journal of Neurochemistry. 103: 617-25. PMID 17725581 DOI: 10.1111/J.1471-4159.2007.04812.X  0.639
2006 Allen PB, Zachariou V, Svenningsson P, Lepore AC, Centonze D, Costa C, Rossi S, Bender G, Chen G, Feng J, Snyder GL, Bernardi G, Nestler EJ, Yan Z, Calabresi P, et al. Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. Neuroscience. 140: 897-911. PMID 16600521 DOI: 10.1016/J.Neuroscience.2006.02.067  0.613
2006 Zachariou V, Bolanos CA, Selley DE, Theobald D, Cassidy MP, Kelz MB, Shaw-Lutchman T, Berton O, Sim-Selley LJ, Dileone RJ, Kumar A, Nestler EJ. An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nature Neuroscience. 9: 205-11. PMID 16415864 DOI: 10.1038/Nn1636  0.826
2006 Zachariou V, Sgambato-Faure V, Sasaki T, Svenningsson P, Berton O, Fienberg AA, Nairn AC, Greengard P, Nestler EJ. Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 555-62. PMID 16123776 DOI: 10.1038/Sj.Npp.1300832  0.738
2005 McClung CA, Nestler EJ, Zachariou V. Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 6005-15. PMID 15976090 DOI: 10.1523/Jneurosci.0062-05.2005  0.735
2005 Picciotto MR, Hawes JJ, Brunzell DH, Zachariou V. Galanin can attenuate opiate reinforcement and withdrawal. Neuropeptides. 39: 313-5. PMID 15944028 DOI: 10.1016/j.npep.2004.12.001  0.812
2005 Hawes JJ, Brunzell DH, Wynick D, Zachariou V, Picciotto MR. GalR1, but not GalR2 or GalR3, levels are regulated by galanin signaling in the locus coeruleus through a cyclic AMP-dependent mechanism. Journal of Neurochemistry. 93: 1168-76. PMID 15934937 DOI: 10.1111/J.1471-4159.2005.03105.X  0.797
2004 McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ. DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Research. Molecular Brain Research. 132: 146-54. PMID 15582154 DOI: 10.1016/J.Molbrainres.2004.05.014  0.788
2004 Gold SJ, Zachariou V. In situ hybridization analysis of RGS mRNA regulation and behavioral phenotyping of RGS mutant mice. Methods in Enzymology. 389: 205-29. PMID 15313568 DOI: 10.1016/S0076-6879(04)89013-X  0.376
2003 Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O, Neve RL, Sim-Selley LJ, Selley DE, Gold SJ, Nestler EJ. Essential role for RGS9 in opiate action. Proceedings of the National Academy of Sciences of the United States of America. 100: 13656-61. PMID 14595021 DOI: 10.1073/Pnas.2232594100  0.827
2003 Zachariou V, Brunzell DH, Hawes J, Stedman DR, Bartfai T, Steiner RA, Wynick D, Langel U, Picciotto MR. The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal. Proceedings of the National Academy of Sciences of the United States of America. 100: 9028-33. PMID 12853567 DOI: 10.1073/Pnas.1533224100  0.819
2003 Rahman Z, Schwarz J, Gold SJ, Zachariou V, Wein MN, Choi KH, Kovoor A, Chen CK, DiLeone RJ, Schwarz SC, Selley DE, Sim-Selley LJ, Barrot M, Luedtke RR, Self D, et al. RGS9 modulates dopamine signaling in the basal ganglia. Neuron. 38: 941-52. PMID 12818179 DOI: 10.1016/S0896-6273(03)00321-0  0.804
2003 Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, Eisch AJ, Yanagisawa M, Nestler EJ, DiLeone RJ. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 3106-11. PMID 12716916 DOI: 10.1523/Jneurosci.23-08-03106.2003  0.788
2002 Barrot M, Olivier JD, Perrotti LI, DiLeone RJ, Berton O, Eisch AJ, Impey S, Storm DR, Neve RL, Yin JC, Zachariou V, Nestler EJ. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proceedings of the National Academy of Sciences of the United States of America. 99: 11435-40. PMID 12165570 DOI: 10.1073/Pnas.172091899  0.794
2002 Shaw-Lutchman TZ, Barrot M, Wallace T, Gilden L, Zachariou V, Impey S, Duman RS, Storm D, Nestler EJ. Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 3663-72. PMID 11978842 DOI: 10.1523/Jneurosci.22-09-03663.2002  0.537
2002 Zachariou V, Benoit-Marand M, Allen PB, Ingrassia P, Fienberg AA, Gonon F, Greengard P, Picciotto MR. Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1. Biological Psychiatry. 51: 612-20. PMID 11955461 DOI: 10.1016/S0006-3223(01)01318-X  0.605
2001 Picciotto MR, Caldarone BJ, Brunzell DH, Zachariou V, Stevens TR, King SL. Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacology & Therapeutics. 92: 89-108. PMID 11916531 DOI: 10.1016/S0163-7258(01)00161-9  0.775
2001 Zachariou V, Caldarone BJ, Weathers-Lowin A, George TP, Elsworth JD, Roth RH, Changeux JP, Picciotto MR. Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 576-89. PMID 11282258 DOI: 10.1016/S0893-133X(00)00224-4  0.726
2001 Zachariou V, Georgescu D, Kansal L, Merriam P, Picciotto MR. Galanin receptor 1 gene expression is regulated by cyclic AMP through a CREB-dependent mechanism. Journal of Neurochemistry. 76: 191-200. PMID 11145992 DOI: 10.1046/j.1471-4159.2001.00018.x  0.511
2000 Caldarone BJ, George TP, Zachariou V, Picciotto MR. Gender differences in learned helplessness behavior are influenced by genetic background. Pharmacology, Biochemistry, and Behavior. 66: 811-7. PMID 10973520 DOI: 10.1016/S0091-3057(00)00271-9  0.675
2000 Zachariou V, Thome J, Parikh K, Picciotto MR. Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 127-37. PMID 10882839 DOI: 10.1016/S0893-133X(00)00094-4  0.55
2000 Picciotto MR, Caldarone BJ, King SL, Zachariou V. Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 451-65. PMID 10731620 DOI: 10.1016/S0893-133X(99)00146-3  0.736
1999 Zachariou V, Parikh K, Picciotto MR. Centrally administered galanin blocks morphine place preference in the mouse. Brain Research. 831: 33-42. PMID 10411981 DOI: 10.1016/S0006-8993(99)01476-6  0.553
1997 Picciotto MR, Zoli M, Zachariou V, Changeux JP. Contribution of nicotinic acetylcholine receptors containing the beta 2-subunit to the behavioural effects of nicotine. Biochemical Society Transactions. 25: 824-9. PMID 9388554 DOI: 10.1042/Bst0250824  0.533
1997 Kuhn FA, Gonzalez S, Rodriguez M, Siller CC, Zachariou V, Goldstein BD. Capsaicin's effect on rat nasal mucosa substance P release: experimental basis for vasomotor rhinitis treatment. American Journal of Rhinology. 11: 313-6. PMID 9292182 DOI: 10.2500/105065897781446649  0.456
1997 Zachariou V, Goldstein BD. Dynorphin-(1-8) inhibits the release of substance P-like immunoreactivity in the spinal cord of rats following a noxious mechanical stimulus. European Journal of Pharmacology. 323: 159-65. PMID 9128834 DOI: 10.1016/S0014-2999(97)00038-1  0.485
1997 Zachariou V, Goldstein BD, Yeomans DC. Low but not high rate noxious radiant skin heating evokes a capsaicin-sensitive increase in spinal cord dorsal horn release of substance P. Brain Research. 752: 143-50. PMID 9106450 DOI: 10.1016/S0006-8993(96)01466-7  0.433
1996 Zachariou V, Goldstein BD. Delta-Opioid receptor modulation of the release of substance P-like immunoreactivity in the dorsal horn of the rat following mechanical or thermal noxious stimulation. Brain Research. 736: 305-14. PMID 8930337 DOI: 10.1016/0006-8993(96)00718-4  0.507
1996 Zachariou V, Goldstein BD. Kappa-opioid receptor modulation of the release of substance P in the dorsal horn. Brain Research. 706: 80-8. PMID 8720494 DOI: 10.1016/0006-8993(95)01182-X  0.508
Show low-probability matches.